Search

everythinglearnresearchcommunity

for

Search:↓

Using both minoxidil and finasteride together is more effective for male hair loss than using either one alone.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Combining PRP and laser treatments improves hair density best for androgenetic alopecia.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Primary cicatricial alopecia, a rare disorder causing permanent hair loss, is hard to diagnose and treat, with treatments like anti-inflammatory drugs and steroids offering varied results and no guaranteed cure. Psychological support for patients is important, and future research should aim to identify causes of the condition.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Alopecia treatments improve life quality but side effects can lessen this benefit; better use of quality of life measures is needed.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

Treating non-classic congenital adrenal hyperplasia is complex because the benefits of hormone treatment must be weighed against potential health risks.

The article concludes that treating hair loss requires careful research, understanding the causes, and personalized treatment plans.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

Tadalafil and Finasteride may help treat aggressive melanoma.

Food intake, not genetics, affects how the body processes tadalafil and finasteride.

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

Platelet-rich plasma can increase hair density and may help treat some skin conditions, but it's costly, not FDA-approved, and needs more research.

PRP can help treat hair loss but needs standardized methods for best results.

The supplement significantly improves hair density and appearance in people with hair loss.

RF-based therapies might help treat hair loss.

Non-drug therapies show promise for hair regrowth but need more research.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Low-dose oral minoxidil can help treat male and female pattern hair loss, especially in those who can't use topical treatments or have heart health issues.

Some medications might contribute to male infertility, with finasteride showing a high number of reports.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Kerascalp hair serum was found to be safe and effective in improving hair growth and strength in people with mild to moderate hair loss.

Low-dose oral Minoxidil is an effective treatment for hair loss with minimal serious side effects.